| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 03/14/2007 | CN1930163A Novel dichloro-phenyl-pyrido [2,3-d] pyrimidine derivates, their manufacture and use as pharmaceutical agents |
| 03/14/2007 | CN1930155A Acylaminothiazole derivatives, preparation method thereof and use of same in therapeutics |
| 03/14/2007 | CN1930145A Cycloalkanopyridine derivative |
| 03/14/2007 | CN1930138A Substituted morpholine and thiomorpholine derivatives |
| 03/14/2007 | CN1930126A 吡啶酮衍生物 Pyridine derivatives |
| 03/14/2007 | CN1930123A Medicinal composition for prevention or treatment of overactive bladder accompanying nervous disorder |
| 03/14/2007 | CN1929853A Neuroprotective dietary supplement |
| 03/14/2007 | CN1929847A Fasudil-containing preparation and method of improving stability thereof |
| 03/14/2007 | CN1929846A Methods for modulating glutamate receptors for treating neuropsychiatric disorders comprising the use of modulators of serum and glucocorticoid inducible kinases |
| 03/14/2007 | CN1929839A Controlled release pharmaceutical composition of tolperisone for oral administration |
| 03/14/2007 | CN1929837A Non-immunosuppressive immunophilin ligands as neuroprotective and/or neuroregenerative agents |
| 03/14/2007 | CN1929829A (S)-2-N-propylamino-5-hydroxytetralin as a D3-agonist |
| 03/14/2007 | CN1929824A Soft gelatin capsule comprising omega-3-polyunsaturated fatty acid |
| 03/14/2007 | CN1929816A Pharmaceutical compositions comprising midazolam in a high concentration |
| 03/14/2007 | CN1927385A NK 3 receptor in vivo assay |
| 03/14/2007 | CN1927363A Health food, its preparation method and application |
| 03/14/2007 | CN1927361A Nutritious health food for protecting liver and neutralizing the effect of alcohol and its preparation |
| 03/14/2007 | CN1927333A traditional Chinese medicine applied externally for treating epilepsy |
| 03/14/2007 | CN1927316A Medicine for treating facial nerve paralysis |
| 03/14/2007 | CN1927285A Medicament for neutralizing the effect of alcohol and protecting liver |
| 03/14/2007 | CN1927271A Receptor smoking giving up plaster |
| 03/14/2007 | CN1927253A Compound recipe medicine for curing insomnia and its preparation method |
| 03/14/2007 | CN1927248A Application of semen desc urainia oil in preparation of composition with cranial nerve regulation function |
| 03/14/2007 | CN1927243A Application of marsilea and water extraction in preparation of medicine for relieving alcoholism and hepatoprotection |
| 03/14/2007 | CN1927212A Application of resveratrol glycoside in preparation of drug for treating Parkinson disease |
| 03/14/2007 | CN1927205A New association of agomelatine and a noradrenalin reuptake inhibitor, and pharmaceutical compositions containing them |
| 03/14/2007 | CN1927194A New association of agomelatine with a mood stabilizer, and pharmaceutical compositions comprising them |
| 03/14/2007 | CN1927193A Use of agomelatine for the preparation of medicaments for the treatment of sleep disorders in depressed patients |
| 03/14/2007 | CN1304581C Compositions and methods for treating neurodegenerative diseases |
| 03/14/2007 | CN1304422C Non-amidated omega-conotoxin VIIA and its prepn process and application |
| 03/14/2007 | CN1304390C Novel gamma secretase inhibitors |
| 03/14/2007 | CN1304389C Piperidine derivatives useful as CCR5 antagonists |
| 03/14/2007 | CN1304383C Benzothiazole derivatives |
| 03/14/2007 | CN1304382C New p2X* receptor antagonists for use in the treatment of inflammatory immune or cardiovascular diseases |
| 03/14/2007 | CN1304377C Metalloproteinase inhibitors |
| 03/14/2007 | CN1304375C Pyrazoloanthrone and derivatives thereof as JNK inhibitors and their compositions |
| 03/14/2007 | CN1304374C Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition |
| 03/14/2007 | CN1304373C Method for preparing aripiprazole and its intermediate |
| 03/14/2007 | CN1304052C Medicinal compositions for application to mucosa |
| 03/14/2007 | CN1304047C Use of long pentraxin PTX3 for treatment of diseases caused by altered activation of growth factor FGF-2 |
| 03/14/2007 | CN1304045C Arthralgia removing pills and their preparation |
| 03/14/2007 | CN1304040C Sobering up sonvenient beverage |
| 03/14/2007 | CN1304039C Chinese medicine composition with functions of reducing blood-pressure, reducing-fat, anti-dizzy and calming wind, its preparing method and use |
| 03/14/2007 | CN1304022C Medicine for treating depression |
| 03/14/2007 | CN1304009C Nutritional preparation comprising ribose and folic acid and medical use thereof |
| 03/14/2007 | CN1303996C use of substituted aminomethyl chromans for the treatment of movement disorders and of adverse effects induced by drugs administered to treat extrapyramidal movement disorders |
| 03/14/2007 | CN1303991C Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivative and process for preparing the same |
| 03/14/2007 | CN1303990C Sodium ferulate oral disintegrating tablet and its preparation process |
| 03/14/2007 | CN1303986C Patch |
| 03/13/2007 | US7189878 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 03/13/2007 | US7189854 Reacting 4-(2-hydroxyethyl)piperazine and 2-((2-methyl,6-chloro-pyrimidin-4-yl)-amino),5-(2-chloro,6-methyl-phenyl)thiazole to obtain 2-((2-hydroxyethyl)piperazin-4-yl)-(2-methylpyrimidin-6,4-ylene)amino-),5-(2-chloro,6-methyl-phenyl)thiazole; antiarthritic,-tumor, -carcinogentic agents; immunology |
| 03/13/2007 | US7189837 Cell surface molecule-induced macrophage activation |
| 03/13/2007 | US7189820 Antibody for use in the treatment, prevention and diagnosis of cancer, autoimmune, arthritic and graft vs. host diseases |
| 03/13/2007 | US7189819 Humanized antibodies that recognize beta amyloid peptide |
| 03/13/2007 | US7189761 Nitric oxide donor composition and method for treatment of anal disorders |
| 03/13/2007 | US7189758 2-Benzyl-2-hydroxy-4-methyl-4-phenylpentanoic acid (1-oxo-1,3-dihydroisobenzofuran-5-yl)amide for example; treating type II diabetes, obesity, hypertension, arteriosclerosis, or glaucoma |
| 03/13/2007 | US7189756 Pyrrolidine derivatives |
| 03/13/2007 | US7189751 Drugs comprising phospholipase enzyme inhibitor; chemical synthesis; anaphylaxis, allergic inflammation, asthma, rhinitis, bronchitis, pneumonia, adult respiratory distress syndrome, inflammatory intestine disorder, Crohn's disease, ulcerative colitis, ischemia/reperfusion injuries, vasculitis |
| 03/13/2007 | US7189749 Substituted phenoxyacetic acids |
| 03/13/2007 | US7189745 For use in therapy of diseases, in a mammal, in which inappropriate, excessive or undesirable angiogenesis has occurred and/or where excessive Tie2 receptor activity has occurred, cytokine antagonist, antiarthritic agent, for therapy of diabetic retinopathy |
| 03/13/2007 | US7189742 For therapy of disorder associated with elevated levels of 5-HT (5-hydroxytryptamine; serotonin) resultant from newly synthesised 5-HT, anxiety, depression, migraine and sleep apnoea |
| 03/13/2007 | US7189739 Antiinflammatory agents; cardiovascular disorders; rheumatic disorders |
| 03/13/2007 | US7189738 Substituted isoindoles and their use thereof |
| 03/13/2007 | US7189730 A2A adenosine receptor antagonists |
| 03/13/2007 | US7189720 Selective NPY (Y5) antagonists |
| 03/13/2007 | US7189714 Administering quinoline derivative as analgesic |
| 03/13/2007 | US7189713 Piperidine derivatives |
| 03/13/2007 | US7189711 Muscle relaxants; central nervous system disorders; Parkinson's disease; Alzheimer's disease; strokes |
| 03/13/2007 | US7189706 C2,5′-disubstituted and N6,C2,5′-trisubstituted adenosine derivatives and pharmaceutical compositions containing them |
| 03/13/2007 | US7189701 Tetrapeptide stimulating functional activity of neurons pharmacological agent based thereon and method of use thereof |
| 03/13/2007 | US7189525 Human enzymes of the metalloprotease family |
| 03/13/2007 | US7189420 Composition comprising wenguanguo extracts, methods for preparing same and uses thereof |
| 03/13/2007 | US7189404 Strain selection of pneumococcal surface proteins |
| 03/13/2007 | US7189389 Pharmaceutical composition of human interferon-α2 and interferon α8 subtypes |
| 03/13/2007 | CA2420895C Method for treating erectile dysfunction and increasing libido in men |
| 03/13/2007 | CA2398182C Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes |
| 03/13/2007 | CA2387533C Purine derivatives |
| 03/13/2007 | CA2381819C New benzimidazolone derivatives having mixed serotonine and dopamine receptors affinity |
| 03/13/2007 | CA2315227C Arylpiperazines having activity at the serotonin 1a receptor |
| 03/13/2007 | CA2192899C Composition containing l-carnitine and hydroxycitric acid |
| 03/09/2007 | CA2558764A1 New association between agomelatine and a thymoregulator and the pharmaceutical compositions that contain it |
| 03/09/2007 | CA2558762A1 Use of agomelatine to obtain medications for the treatment of sleep disorders in depressed patients |
| 03/08/2007 | WO2007028133A2 Treatment and prevention of vascular dementia |
| 03/08/2007 | WO2007028131A1 6-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-BENZO[d]AZEPINES AS 5-HT2C RECEPTOR AGONISTS |
| 03/08/2007 | WO2007028082A1 6-substituted- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 03/08/2007 | WO2007026966A1 Thiomorpholine compound and process for preparing the same |
| 03/08/2007 | WO2007026962A1 Phenylene derivative |
| 03/08/2007 | WO2007026961A1 Aδ NERVE FUNCTION INHIBITOR AND PREVENTIVE OR REMEDY FOR NEUROPATHIC PAIN |
| 03/08/2007 | WO2007026959A2 Derivatives of 4-piperazin-1-yl-4-benz0 [b] thiophene suitable for the treatment of cns disorders |
| 03/08/2007 | WO2007026836A1 Novel therapeutic agent derived from marine organism |
| 03/08/2007 | WO2007026771A1 Injection for intravenous drip |
| 03/08/2007 | WO2007026567A1 ANALGESIC AGENT COMPRISING p75NTR INHIBITOR AS ACTIVE INGREDIENT |
| 03/08/2007 | WO2007026224A2 5-ht1b antagonist composition for depression, anxiety and cognition |
| 03/08/2007 | WO2007026219A2 Combinations of a 5-ht1b antagonist with a noradrenalin re-uptake inhibitor or a serotonin noradrenalin reutake inhibitor for treating cns conditions |
| 03/08/2007 | WO2007026215A1 Pyrazole derivatives as cannabinoid receptor ligands, pharmaceutical compositions containing? them, and processes for their preparation |
| 03/08/2007 | WO2007026097A1 Novel indole compounds |
| 03/08/2007 | WO2007025991A2 Treatment of optic neuritis |
| 03/08/2007 | WO2007025978A1 Novel azabicyclo[3.2.1]oct-2-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 03/08/2007 | WO2007025596A1 Pyrazolo [3 , 4-d] azepine derivatives as histamine h3 antagonists |
| 03/08/2007 | WO2007025481A1 Process for preparing (s)-n-ethyl-n-methyl-3-[1-(dimethylamino) ethyl]-phenyl carbamate and tartrate thereof |